down arrow

Abbott India

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE358A01014
  • NSEID: ABBOTINDIA
  • BSEID: 500488
INR
28,857.00
30.15 (0.1%)
BSENSE

Dec 05

BSE+NSE Vol: 8.87 k

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Abbott India Ltd. stock-summary
stock-summary
Abbott India Ltd.
Mid Cap
Pharmaceuticals & Biotechnology
Abbott India Ltd. is one of the leading multinational pharmaceutical companies in India and operates with an owned manufacturing facility in Goa and various independent contract/third party manufacturers based across the country. The Company sells its products through independent distributors primarily within India.
Company Coordinates stock-summary
Company Details
Unit No 3 Corporate Park, Sion Trombay Road Chembur Mumbai Maharashtra : 400071
stock-summary
Tel: 91-22-67978888/50461000/2000/1119
stock-summary
http://www.abbott.co.in
stock-summary
investorrelations.india@abbott.com
Registrar Details
Karvy Computershare Pvt Ltd., Karvy Selenium, Tower-B Plot No 31 & 32, Survey No 116/22, 115/24, 115/25, Financial District, Nanakramguda, Serilingampally, Mandal Ranga Reddy Dist, Hyderabad
stock-summary Capital Structure
Capital Structure stock-summary
Present Equity Capital
INR 21.25 Cr
Number of Shares
2.12 Cr
Face Value
INR 10.0
Date
Number
of Shares(Cr)
Equity
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
07-Sep-2011
2.12
21.25
7574062
10
Amalgamation
07-Sep-2011
2.12
21.25
7574062
10
Amalgamation
14-Aug-2008
1.37
13.68
-797500
10
Buy Back of Shares
14-Aug-2008
1.37
13.68
-797500
10
Buy Back of Shares
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 36 Schemes (7.78%)

FIIs

Held by 11 FIIs (0.16%)

Promoter with highest holding

Abbott Capital India Limited (50.44%)

Highest Public shareholder

Sbi Large & Midcap Fund (2.66%)

Individual Investors Holdings

13.43%

stock-summary Board of Directorsstock-summary
stock-summary
Management
Designation
Remuneration
Munir Shaikh
Chairman (Non-Executive)
31.0 lacs
Kaiyomarz Marfatia
Non Executive Director
23.0 lacs
Ambati Venu
Non Executive Director
0
Anisha Motwani
Independent Director
30.0 lacs
Sudarshan Jain
Independent Director
28.0 lacs
Shalini Kamath
Independent Director
30.0 lacs
Sabina Ewing
Non Executive Director
0
Vivek Vasudev Kamath
Managing Director
6.43 cr
Mahadeo Karnik
Director
0
stock-recommendationRaw Materials
Raw Materials Dashboard stock-summary
Raw Materials
Amount(Rs Cr)
% of RM Cost
 
Icon
No Data Available
stock-recommendation Finished Goods
Finished Goods Dashboard stock-summary
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Injectables
1,507.14
40.97%
Tablets
1,421.77
38.65%
Liquids
512.56
13.93%
 
40.97
Injectables
59.03
Injectables
38.65
Tablets
61.35
Tablets
13.93
Liquids
86.07
Liquids
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
1,757 Cr
(Quarterly Results - Sep 2025)
Net Profit:
415 Cr
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

INR 61,517 Cr (Mid Cap)

stock-summary
P/E

41.00

stock-summary
Industry P/E

34

stock-summary
Dividend Yield

1.65%

stock-summary
Debt Equity

-0.27

stock-summary
Return on Equity

37.62%

stock-summary
Price to Book

15.27

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."